Compare ALVO & OCFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALVO | OCFC |
|---|---|---|
| Founded | 2013 | 1902 |
| Country | Luxembourg | United States |
| Employees | 1460 | 1007 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | ALVO | OCFC |
|---|---|---|
| Price | $3.54 | $19.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $8.00 | ★ $21.33 |
| AVG Volume (30 Days) | 366.2K | ★ 577.9K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.24% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.28 | $47.51 |
| Revenue Next Year | $18.63 | $21.97 |
| P/E Ratio | $18.20 | ★ $16.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $16.09 |
| 52 Week High | $11.85 | $20.61 |
| Indicator | ALVO | OCFC |
|---|---|---|
| Relative Strength Index (RSI) | 48.90 | 57.96 |
| Support Level | $3.03 | $18.97 |
| Resistance Level | $3.93 | $19.37 |
| Average True Range (ATR) | 0.18 | 0.42 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 51.04 | 60.68 |
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.